Qiagen Targeted RNA Panels
Qiagen has launched more than 170 new QIAseq targeted RNA panels for gene expression profiling. The panels enable researchers to select from over 20,000 human genes and IncRNA to survey expression fold changes and discover interactions between genes, cellular phenotypes, and disease processes, said the company. The panel technology combines the flexibility and throughput of NGS with the accuracy of qPCR and uses only 20 nanograms of starting RNA material to analyze hundreds of genes. QIAseq targeted RNA panels cover an extensive range of disease- and signaling pathway-focused genes, with each panel targeting 100 to 500 genes. The panels can also be customized to include other genes of clinical and biological interest with the flexibility to analyze from 12 to 1,000 genes simultaneously.